DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 59.00
+1.50 (2.61%)
At close: Feb 11, 2026
DV Biomed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 52.39 | 89.08 | 162.91 | 281.26 | 304.58 | 301.4 |
Depreciation & Amortization | 17.61 | 18.3 | 23.05 | 180.16 | 176.26 | 171.23 |
Other Amortization | 7.72 | 1.19 | 1.78 | 3.41 | -7.51 | 9.8 |
Loss (Gain) From Sale of Assets | -5.35 | -5.35 | 0.02 | 2.01 | 4.73 | -96.79 |
Loss (Gain) From Sale of Investments | -1.35 | -1.79 | -11.45 | -5.47 | -0.3 | -0.14 |
Loss (Gain) on Equity Investments | - | - | - | 26.15 | 27.97 | 24.74 |
Stock-Based Compensation | - | - | - | - | - | 0.9 |
Provision & Write-off of Bad Debts | -0.06 | -1.29 | 1.11 | -0.6 | -1.79 | 1.85 |
Other Operating Activities | 9.83 | 10.46 | -81.32 | -3.66 | 15.26 | -33.36 |
Change in Accounts Receivable | 47.77 | 48.73 | -45.4 | 53.24 | -33.76 | 5.1 |
Change in Inventory | -35.05 | -3.12 | 10.27 | -1.83 | -20.44 | 93.71 |
Change in Accounts Payable | 33.95 | 4.85 | 7.62 | -5.12 | 19.19 | -33.86 |
Change in Unearned Revenue | 6.18 | 2.01 | -2.41 | 0.94 | 19.77 | 1.01 |
Change in Other Net Operating Assets | 10.41 | -43.2 | -5.92 | -0.17 | 18.64 | 17.47 |
Operating Cash Flow | 143.51 | 119.04 | 69.61 | 522.58 | 522.59 | 463.07 |
Operating Cash Flow Growth | 309.20% | 71.00% | -86.68% | -0.00% | 12.85% | 104.27% |
Capital Expenditures | -11.8 | -1.52 | -2.52 | -120.76 | -62.22 | -93.3 |
Sale of Property, Plant & Equipment | 74.48 | 74.48 | - | 3.37 | - | 1 |
Divestitures | 0.89 | 1.73 | -9.01 | - | - | -192.04 |
Sale (Purchase) of Intangibles | -16.13 | -4.7 | - | -1.46 | -7.09 | -0.6 |
Investment in Securities | -133.38 | -117.89 | 79.44 | -77.83 | -38.26 | -4.54 |
Other Investing Activities | -0.59 | -0.31 | 2.72 | -1.32 | 2.8 | -1.19 |
Investing Cash Flow | -62.19 | -30.88 | 70.63 | -198.01 | -104.77 | -290.67 |
Short-Term Debt Issued | - | - | - | - | 30 | 20 |
Total Debt Issued | - | - | - | - | 30 | 20 |
Short-Term Debt Repaid | - | - | - | - | -30 | -20 |
Long-Term Debt Repaid | - | -32.4 | -10.35 | -77.2 | -67.92 | -76.37 |
Total Debt Repaid | -37.93 | -32.4 | -10.35 | -77.2 | -97.92 | -96.37 |
Net Debt Issued (Repaid) | -37.93 | -32.4 | -10.35 | -77.2 | -67.92 | -76.37 |
Repurchase of Common Stock | - | - | - | -42.16 | - | -58.53 |
Common Dividends Paid | -57.78 | -80.43 | -298.96 | -306.65 | -325.94 | -97.99 |
Other Financing Activities | -81.68 | 9.52 | 0.11 | - | - | - |
Financing Cash Flow | -177.39 | -103.3 | -309.2 | -426.01 | -393.86 | -232.89 |
Foreign Exchange Rate Adjustments | -10.42 | 2.88 | 4.22 | 0.64 | 0.05 | -0.42 |
Net Cash Flow | -106.49 | -12.27 | -164.75 | -100.79 | 24.01 | -60.91 |
Free Cash Flow | 131.7 | 117.52 | 67.09 | 401.83 | 460.37 | 369.77 |
Free Cash Flow Growth | 300.41% | 75.17% | -83.30% | -12.72% | 24.50% | 416.41% |
Free Cash Flow Margin | 18.48% | 20.49% | 10.84% | 21.53% | 25.20% | 20.41% |
Free Cash Flow Per Share | 5.41 | 4.82 | 2.75 | 16.43 | 18.68 | 14.88 |
Cash Interest Paid | 2.32 | 1.68 | 0.16 | 5.29 | 4.45 | 4.78 |
Cash Income Tax Paid | 17.73 | 18.25 | 77.32 | 84.02 | 73.45 | 63.86 |
Levered Free Cash Flow | 104.3 | 68.79 | 78.2 | 329.69 | 374.48 | 315.28 |
Unlevered Free Cash Flow | 105.75 | 69.84 | 78.3 | 332.95 | 377.26 | 318.27 |
Change in Working Capital | 63.26 | 9.27 | -35.84 | 47.06 | 3.39 | 83.44 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.